glucocorticoids and oxidative stress

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 18, Issue 2, 2007, Pages 115-128

  Baicc J ^a   Bjelakovic G ^a   Pavlovic D ^a   Kocic G ^a   Jevtovic T ^a   Stojanovic I ^a   Beninati, S ^b   Saranac L J ^c   Kamenov, B ^c   Bjelakovic B ^c  

^a Institute of Biochemistry   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c University of Ni   (Italy)

Author keywords

glucocorticoids; nitric oxide (NO); oxidative stress; tetrahydrobiopterin (BH4); unwanted effects

Indexed keywords

GLUCOCORTICOID; TETRAHYDROBIOPTERIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; BIOPTERIN; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 34547628656     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2007.18.2.115     Document Type: Article

References (27)

1. Rhen, T, Cildowski, AJ. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl JMed 2005;353(16): 1711–23.
2. Sionov, RV, Cohen, O, Kfir, S, Zilberman, Y, Yefenof, E. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med 2006;203(1):189–201.
3. Boumpas, DT, Chrousos, GP, Wilder, RL, Cupps, TR, Balow, JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119(12);1198–208.
4. Pitzalis, C, Piupitone, N, Perretti, M Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann NY Acad Sei 2002;996:108–18.
5. Chrousos, PG. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332(20);1351–63.
6. Elenkov, JI, Chrousos, PG. Stress hormones, proinflammatory and antiinflammatory cytokines and autoimmunity. Ann NY Acad Sei 2002; 66:290–303.
7. Pickle, S. Glucocorticoid-induced apoptosis: the role of reactive oxygen species and the proteasome. Thesis submitted to the Miami University Honor Program, May, Oxford, Ohio, USA, 2005.
8. luchi, T, Akaike, M, Mitsui, T, Ohshima, Y, Shintani, Y, Azuma, H, et al. Glucocorticoid excess induce superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81–102.
9. Tonomura, N, McLaughlin, K, Grimm, L, Goldsby, RA, Osborne, BA. Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol 2003; 170(5): 2469–78.
10. Ferioli, EM, Pinottia, O, Pironaa, L. Polyamine oxidase activity in lymphoid tissues of glucocorticoid-treated rats. Biochem Pharmacol 1999;58(12): 907–14.
11. Hegarts, C, Andersson, G, Oredsson, MS Changes in polyamine metabolism during glucocorticoid-induced programmed cell death in mouse thymus. Cell Biol Int 2000;24(12)871–80.
12. Bjelakovic, G, Pavlovic, D, Stojanovic, I, Jevtovic, T, Nikolic, J, Kocic, G. Effects of glucocorticoids on polyamine metabolism in liver and spleen of guinea pig during sensitization. Amino Acids 2006;31(4):457–62.
13. Ishii, M, Shimizu, S, Yamamotoo, T, Momose, K, Kuroiwa, Y. Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content Life Sci 1997;61(7):739–47.
14. Zalba, G, SanJose, G, Moreno, UM, Fortuno, AM, Fortuno, A, Beaumont, JF, et al. Oxidative stress in arterial hypertension. Role of NAD(P)H oxidase. Hypertension 2001;38(6): 1395–1414.
15. Ng, MK, Celermajer, DS. Glucocorticoid treatment and cardiovascular disease. Heart 2004;90:829–30.
16. Rogers, MK, Bonar, AC, Estrella, LJ, Yang, S Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 2002;283:H1922–28.
17. Schafer, CS, Wallerath, T, Closs, IE, Schmidt, C, Schwarz, MP, Forstermann, U, et al. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 2005;288:H436–44.
18. Wallerath, T, Witte, K, Schafer, CS, Schwartz, MP, Prellwitz, W, Wohlfart, P, et al. GTP cyclohydrolase 1 downregulation contributes to glucocorticoid hypertension in rats. Hypertension, 2003;41(Part 2):669–74.
19. Lehr, HA, Lemmer, B, Forstermann, U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoidmediated hypertension. Proc Natl Acad Sci USA 1999;96(23): 13357–62.
20. Mitchell, BM, Dorrance, AM, Webb, RC. GTP cyclohydrolase 1 down-regulation contributes to glucocorticoid hypertension in rats. Hypertension 2003;41(3 Pt 2):669–74.
21. Madeddu, P. Correction of endothelial dysfunction by tetrahydrobiopterin: new hope for the treatment of arterial hypertension? J Hypertens 2005;23(7): 1335–36.
22. Tiefenbacher, PC, Bleeke, T, Vahl, C, Amann, K, Vogt, A, Kubier, W Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 2000;102:2172–79.
23. Cosentino, F, Katusic, SZ. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries Circulation 1995; 91:139–44.
24. Thony, B, Auerbach, G, Blau, N Tetrahydrobiopterin biosynthesis, regeneration and functions Biochem J 2000;347:1–16.
25. Bjelakovic, G, Jevtovic-Stoimenov, T, Bjelakovic, B, Stojanovic, I. Biochemical functions and clinical importance of unconjugated pteridines. Facta Universitatis Series Med Biol 2004;11(2):49–54.
26. Mitchell, BM, Webb, C. Glucocorticoid-Induced Hypertension and Tetrahydrobiopterin (BH4), a common cofactor for the production of vasoactive molecules. Curr Hypertens Rev 2005;1(1):1–6.
27. Brett, MM, Anne, MD, Eniki, AM, Clinton, RC. Glucocorticoids decrease GTP cyclohydrolase and tetrahydrobiopterin-dependent vasorelaxation through glucocorticoid receptors. J Cardiovasc Pharmacol 2004;43(1): 8–13.